Chikungunya
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chikungunya
Conditions
Chikungunya
Trial Timeline
Nov 20, 2019 → Jan 19, 2021
NCT ID
NCT03992872About Chikungunya
Chikungunya is a phase 2 stage product being developed by Bavarian Nordic for Chikungunya. The current trial status is completed. This product is registered under clinical trial identifier NCT03992872. Target conditions include Chikungunya.
What happened to similar drugs?
0 of 11 similar drugs in Chikungunya were approved
Approved (0) Terminated (2) Active (9)
Hype Score Breakdown
Clinical
12
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03992872 | Phase 2 | Completed |
Competing Products
20 competing products in Chikungunya